iSERA Lifesciences Ltd
₹0.00▲ +0.00 (+0.00%)
COVIDHLTD·NSE·Information Technology
Market Cap
121.00 Cr
PE Ratio
—
Volume
—
Day High - Low
—
52W High-Low
143.90 - 6.40
₹0.00▲ +0.00 (+0.00%)
Market Cap121.00 Cr
PE Ratio—
Volume—
Day High - Low—
52W High-Low143.90 - 6.40
iSERA Lifesciences Ltd (COVIDHLTD): company summary
iSERA Lifesciences Ltd (COVIDHLTD) is a micro-cap Information Technology company valued at ₹121 crore operating in Computer Software & Consulting on the NSE and BSE.
iSERA Lifesciences Ltd (COVIDHLTD) is a micro-cap Information Technology company valued at ₹121 crore operating in Computer Software & Consulting on the NSE and BSE.
- Financial performance
- Return on equity stands at 6.4%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here; the stock trades at 14.67 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
4.3/10
Weak
Fair Value
Sign in to see
ROE
6.38%
Weak
P/E
—
Debt / Equity
0.20
Low
Industry
Information Technology
Computer Software & Consulting
Overall View
Mixed
Price performance
52W₹6.40
₹143.90
DocStoX take
Supported by growth (9.0), but held back by valuation (0.0). Growth looks strong at 9.0, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Medium confidence4.3
/10
Weak
Quality
Modest
ROE 6.4%
Valuation
Expensive
P/B 14.7× vs 0.6× warranted by ROE
Growth
Strong
Revenue +64.5% 5Y CAGR
Risk
Elevated
D/E 0.20
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹121 Cr
52W High / Low
₹144 / ₹6
Dividend Yield
0.00%
Promoter Holding
58.63%
EPS (TTM)
₹0.14
Book Value
₹9.81
Key highlights
- Revenue compounding 65% a year
- Healthy net margin (44%)
- Low leverage — D/E 0.20
- Loss-making in some of the last 5 years
- Valuation is weak (0.0/10)
3 Positives3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Information Technology stocks · Computer Software & Consulting
Explore iSERA Lifesciences Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
iSERA Lifesciences Ltd peers in Information Technology
Other Information Technology stocks on the NSE & BSE. See the full Information Technology sector list.
Tata Consultancy Services LimitedInfosys LimitedHCL Technologies LimitedWipro LimitedTech Mahindra LimitedLTM LimitedPersistent Systems LimitedOracle Financial Services Software LimitedCoforge LimitedMphasiS LimitedL&T Technology Services LimitedHexaware Technologies Limited
Compare iSERA Lifesciences Ltd with peers
Related tools & concepts
Value iSERA Lifesciences Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing